Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gelatin + thrombin is a combination hemostatic agent used primarily for local control of bleeding during surgery or after trauma. Gelatin acts as an absorbable matrix, providing a scaffold for clot formation, while thrombin is an enzyme that converts fibrinogen to fibrin, accelerating the coagulation cascade and promoting rapid clot formation at the site of application. This combination is typically applied topically—gelatin sponges or matrices are soaked with a solution of thrombin and then placed directly onto bleeding surfaces. The synergistic action enhances hemostasis compared to either component alone. It is widely used in surgical settings where conventional methods (such as suturing or cauterization) are insufficient or impractical[2][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on gelatin + thrombin.